The Therapeutic Goods Administration (TGA) has issued four infringement notices totalling A$10,656 to an unnamed Sydney-based individual for alleged unlawful advertising of CBD oil.

The TGA said it had raised concerns with the alleged offender on a number of occasions warning them they could not make reference to the substance cannabidiol (CBD) in the advertising of CBD Oil or other medicinal cannabis products.

Under the Therapeutic Goods Act 1989, CBD and goods containing CBD are included in Schedule 3, 4 or 8 of the Poisons Standard and cannot be advertised to the public unless included in Appendix H. The TGA further alleged that the CBD oil was not entered, at the time of advertising, in the Australian Register of Therapeutic Goods.

It is alleged the individual referred to a prohibited representation in the website advertising of the CBD oil as a treatment for “cancerous tumours”. It also included a restricted representation in relation to Alzheimer’s Disease. Any claims or references to treating a serious form of a disease, condition, ailment or defect are restricted representations.

The TGA has ordered that the website and social media advertising be removed immediately.